Keywords
COVID-19
hemoperfusion
How to Cite
Abstract
The COVID-19 disease is an infectious disease caused by the SARS-CoV 2 virus whose clinical presentation is very heterogeneous: it can range from asymptomatic people to critically ill patients, with cytokine storm, acute respiratory distress, organ dysfunction and even death. Current therapies for its treatment are aimed at reducing the impact of the inflammatory cascade, and within these we find hemoadsorption technologies such as the CytoSorb membrane. Next, we present a 31-year-old male patient, who consulted due to severe symptoms of COVID-19 and showed an evident clinical and biochemical improvement after using the CytoSorb device. This is the only documented patient in Colombia who has undergone haemoperfusion therapy with this device in conjunction with prolonged intermittent renal replacement therapy and favorable clinical outcomes have been recorded.
References
Daza Arnedo R, Aroca Martínez G, Rico Fontalvo JE, Rey Vela E, Pájaro Galvis NE, Salgado Montiel LG, et al. Terapias de purificación sanguínea en COVID-19. Rev Colomb Nefrol [Internet]. 16 de julio de 2020 [citado 9 de agosto de 2020];7(1):33-4. https://doi.org/10.22265/acnef.7.Supl.2.476
Gonzalez C, Yama E, Yomayusa N, Vargas J, Rico J, Ariza A, et al. Consenso colombiano de expertos sobre recomendaciones informadas en la evidencia para la prevención, diagnóstico y manejo de la lesión renal aguda por SARS-CoV-2/COVID-19. Rev Colomb Nefrol [Internet]. 16 de julio de 2020 [citado 7 de septiembre de 2020];7(1):11-2. https://revistanefrologia.org/index.php/rcn/article/view/473
Bonavia A, Groff A, Karamchandani K, Singbartl K. Clinical Utility of Extracorporeal Cytokine Hemoadsorption Therapy: A Literature Review. Blood Purif [Internet]. 2018 [citado 7 de septiembre de 2020];46(4):337-49. https://doi.org/10.1159/000492379
Soy M, Keser G, Atagündüz P, Tabak F, Atagündüz I, Kayhan S. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clin Rheumatol [Internet]. julio de 2020 [citado 7 de septiembre de 2020];39(7):2085-94. https://doi.org/10.1007/s10067-020-05190-5
Ciceri F, Beretta L, Scandroglio AM, et al. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. Crit Care Resusc. Published online 2020.
Sarzi-Puttini P, Giorgi V, Sirotti S, et al. COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? Clin Exp Rheumatol. Published online 2020.
Napp LC, Ziegeler S, Kindgen-Milles D. Rationale of Hemoadsorption during Extracorporeal Membrane Oxygenation Support. Blood Purif [Internet]. 2019 [citado 7 de septiembre de 2020];48(3):203-14. https://doi.org/10.1159/000500015
Hattori N, Oda S. Cytokine-adsorbing hemofilter: Old but new modality for septic acute kidney injury. Ren Replace Ther. https://doi.org/10.1186/s41100-016-0051-1
Kogelmann K, Jarczak D, Scheller M, Drüner M. Hemoadsorption by CytoSorb in septic patients: A case series. Crit Care. https://doi.org/10.1186/s13054-017-1662-9
Gruda MC, Ruggeberg KG, O'Sullivan P, et al. Broad adsorption of sepsis-related PAMP and DAMP molecules, mycotoxins, and cytokines from whole blood using CytoSorb® sorbent porous polymer beads. PLoS One. Published online 2018. https://doi.org/10.1371/journal.pone.0191676
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2020 Revista Colombiana de Nefrología